fashion -WSS

fashion

author：Wikipedia 2025-09-29 01:39:16 - browse：7688

FogPharma CEO Mathai Mammen Venrock

SAN FRANCISCO — Six months into his tenure as CEO of cancer startup FogPharma, Mathai Mammen is taking the stage at the Westin St. Francis Tuesday for what he’s calling a “big unveil” of how he’s reshaping the biotech. And he’s prepared to go against the grain.

Perhaps the most important thing he’s telling investors at the J.P. Morgan Healthcare Conference is that he plans to eventually pursue a rare Series E round, rather than an IPO or seeking out acquisition offers.

FogPharma last raised money in November 2022, and will need more cash to bring its lead drug past its ongoing Phase 1/2 trial. Most other biotechs in this position are anxiously eyeing the capital markets, hoping that conditions improve and make an IPO more feasible. But Mammen doesn’t see the point, at this stage. “There’s no reason to be a public company. I don’t know why you’d want to be, really,” he told STAT ahead of FogPharma’s presentation.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： AI can’t replace a physician’s gut feeling

Wikipedia

WSS

AI can’t replace a physician’s gut feeling

Rescued Australian man who was adrift 3 months in Pacific with dog 'grateful' to be alive

Key House panel plots a new health care package

Teach medical students about patients with intellectual disabilities

Spinal cord stimulation reduces pain in amputees, study finds

What PEPFAR has meant on the ground in Ukraine

hotspot

fashion

entertainment

Hollywood unions extend contract negotiations for actors

FDA moves to stop vape shops from selling Elf Bar, Esco Bars

Activists slam private health insurers over coverage restrictions

STAT letters to the editor on burnt

Activists slam private health insurers over coverage restrictions

Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug

Sports medicine is finally prioritizing gender equality

Rescued Australian man who was adrift 3 months in Pacific with dog 'grateful' to be alive

leisure time

Radiology is caught between AI's potential and concern for patients

FDA approves RSV monoclonal antibody for infants, toddlers

Pharma patents targeted by Biden in move to slash drug prices

STAT letters to the editor on burnt

As digital health tech proliferates, a new institute aims to cut through hype

AI models in health care face new federal disclosure requirements

knowledge

Wikipedia

explore

entertainment